Eisai Co Ltd will present 8 poster presentations on lemborexant, an investigational agent being studied for the treatment of insomnia, at SLEEP 2019. Long-term safety data from SUNRISE 2 (Study 303), sleep architecture data from...
Read More
Dow has opened a SleepStudio location in North America—the company’s second SleepStudio location...
Read More![A Reference for Referrals [Editor’s Message]](https://sleepreviewmag.com/wp-content/uploads/2019/05/ReferralsAprilSavoy-627x376.jpg)
What makes a clinician-friendly medical referral form? An engineer publishes tested...
Read More
Healthcare innovation startup NightWare Inc, a privately-held digital therapeutics for mental...
Read More
Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep...
Read More